Du Y

No ORCID on file · 80 papers in corpus
2023
Frontiers in endocrinology ·doi:10.3389/fendo.2023.1286391

BackgroundPhthalates are ubiquitously used in a variety of products and have an adverse effect on folliculogenesis. However, previous epidemiological studies on the associations between phthalate exposure and antral follicle count (AFC) pro…

2023
Scientific reports ·doi:10.1038/s41598-023-36286-y

Atosiban was commonly added to improve pregnancy outcomes of patients with repeated embryo implantation failure (RIF). In this study, we aimed to investigate the effect of atosiban before transferring the frozen-thawed embryo to RIF patient…

meta-analysis 2023
Journal of gynecology obstetrics and human reproduction ·doi:10.1016/j.jogoh.2023.102541

Controversial conclusions have been made in previous studies regarding the influence of ultra-long gonadotropin-releasing hormone agonist (GnRH-a) in the reproductive outcomes of women with endometriosis who are undergoing in vitro fertiliz…

2023
International journal of clinical practice ·doi:10.1155/2023/5562495

BackgroundTuberculosis (TB), a multisystemic disease with protean presentation, remains a major global health problem. Although concurrent pulmonary tuberculosis (PTB) and extrapulmonary tuberculosis (EPTB) cases are commonly observed clini…

preprint 2023
·doi:10.21203/rs.3.rs-2542861/v1

Abstract Background: Endometriosis is a widespread disease in reproductive age. Epidemiological studies reported that patients with endometriosis had an increased risk of developing endometriosis-associated ovarian cancer (EAOC). The presen…

article 2023
Reproductive sciences (Thousand Oaks, Calif.) ·doi:10.1007/s43032-023-01227-7

Endometriosis (EM) is a chronic, estrogen-dependent inflammatory disease. Presently, the pathophysiology of EM is still unclear, and numerous studies have established that the immune system plays a major role in the pathophysiology of EM. S…

2023
Journal of multidisciplinary healthcare ·doi:10.2147/jmdh.s432936

ObjectiveFor patients with polycystic ovary syndrome (PCOS) to undergo in vitro fertilization (IVF) and embryo transfer (ET), there has been no consensus regarding which protocol is the most optimal for live birth rate in fresh cycles. We s…

2023
JAMA ·doi:10.1001/jama.2023.5302

ImportanceImplantation failure remains a critical barrier to in vitro fertilization. Prednisone, as an immune-regulatory agent, is widely used to improve the probability of implantation and pregnancy, although the evidence for efficacy is i…

meta-analysis 2023
BMC medicine ·doi:10.1186/s12916-023-02881-z

BACKGROUND: Endometriosis is recognized as a complex gynecological disorder that can cause severe pain and infertility, affecting 6-10% of all reproductive-aged women. Endometriosis is a condition in which endometrial tissue, which normally…

2022
Reproductive biology and endocrinology : RB&E ·doi:10.1186/s12958-021-00873-3

BackgroundInsulin resistance (IR) contributes to ovarian dysfunctions in polycystic ovarian syndrome (PCOS) patients. Serum amyloid A1 (SAA1) is an acute phase protein produced primarily by the liver in response to inflammation. In addition…

2022
Journal of Reproductive Immunology ·doi:10.1016/j.jri.2022.103491

Chemotherapy and radiation treatments are known for deleterious effects on the ovary, which can result in prolonged recovery time before ovarian function resumes, including follicular growth after completion of these therapies. To better un…

other 2022
Pharmacogenomics and personalized medicine ·doi:10.2147/PGPM.S354957

BACKGROUND: Endometriosis (EMS) is a common and highly recurrent gynecological disease characterized by chronic pain and infertility. There are no definitive therapies for endometriosis since the pathogenesis remains undetermined. This stud…

article 2022

Pei Chen, Mengyun Yao, Tao Fang, Chaoshuang Ye, Yongjiang Du, Yang Jin, Ruijin Wu Department of Obstetrics and Gynecology, Women’s Hospital, Zhejiang University School of Medicine, Hangzhou, People’s Republic of ChinaCorrespondence: Ruijin …

article 2022
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology ·doi:10.1080/09513590.2022.2154338

Aims: The primary aim of the current study was to elucidate the function of the stimulator of interferon genes (STING) in the eutopic endometrium of women with endometriosis. Materials and Methods: STING expression and signaling pathways we…

2022
Medicine ·doi:10.1097/md.0000000000032399

BackgroundN6-methyladenosine (m6A) methylation has been reported to participate in inflammatory bowel disease (including Crohn disease [CD]). However, the prognostic and therapeutic implication of m6A methylation modification in CD is still…

article 2022
Frontiers in surgery ·doi:10.3389/fsurg.2022.963686

AIM: The aim of this study was to assess the risk factors for coexisting deep endometriosis (DE) in patients with recurrent ovarian endometrioma (OE). METHODS: We retrospectively reviewed 151 recurrent OE patients who had been diagnosed of…

article 2022
Reproductive biology ·doi:10.1016/j.repbio.2022.100697

Endometriosis is a gynecological disorder seriously affecting the health and life of women of reproductive age. Neuropilin 2 (NRP2) has been indicated to display a high level in ectopic endometrium. Nevertheless, the specific function of NR…

meta-analysis 2022
Journal of gynecology obstetrics and human reproduction ·doi:10.1016/j.jogoh.2022.102446

PURPOSE: The purpose of the study was whether endometriosis influences IVF/ICSI and subsequent pregnancy and obstetric outcomes. METHODS: Searches were performed on PubMed, EMBASE, Medline, and Web of Science. Most of the included studies …

article 2022
Reproductive biomedicine online ·doi:10.1016/j.rbmo.2022.05.007

RESEARCH QUESTION: Adenomyosis is a common uterine disorder of uncertain causes. Can transcriptomic analyses of the endometrium and myometrium reveal potential mechanisms underlying adenomyosis pathogenesis? DESIGN: Transcriptomic profiles…

preprint 2021
·doi:10.21203/rs.3.rs-861230/v1

Abstract Background: Endometriosis is a chronic disease associated with disorder of the oxidative balance and chronic inflammation. Although endometriosis is a benign disease, it has the characteristics properties similar to malignant canc…

article 2021
Scientific reports ·doi:10.1038/s41598-021-98918-5

Gonadotropin-releasing hormone agonist (GnRH-a) is generally added to the improve pregnancy outcomes of hormone replacement therapy cycles among patients with adenomyosis. We aimed to investigate whether adding GnRH-a can result in better p…

preprint 2021
·doi:10.21203/rs.3.rs-506178/v1

Abstract Gonadotropin-releasing hormone agonist(GnRH-a) is generally added to improve pregnancy outcomes of adenomyosis based hormone replacement therapy cycle. Our objective in this study is to investigate whether adding GnRH-a can obtain …

2021
Trials ·doi:10.1186/s13063-021-05834-0

BackgroundPrimary dysmenorrhea (PD) is one of the main gynecological complaints in women of child-bearing age, but limited effective treatments are available. Guizhi Fuling Wan (GFW), one of the most widely known traditional Chinese medicin…

2021
Renal failure ·doi:10.1080/0886022x.2021.1901739

Acute kidney injury (AKI) and chronic kidney disease (CKD) are posing great threats to global health within this century. Studies have suggested that estrogen and estrogen receptors (ERs) play important roles in many physiological processes…

2021
Frontiers in endocrinology ·doi:10.3389/fendo.2021.774646

ObjectiveTo investigate whether patients with a history of recurrent implantation failure (RIF) are associated with adverse perinatal outcomes in singleton live births following frozen-thawed embryo transfer (FET) cycles.DesignRetrospective…